Skip to content

Apotheek Opdebeeck

Active
Private limited companyfounded 20215 years activeKerkhoflei 1, 2580 Putte, BelgiumKBO/BCE: BE 0761.336.370
Summary

The computed 12-month bankruptcy probability of Apotheek Opdebeeck is 4.3% (elevated). The 2024 annual accounts show negative equity (-€11,682) and a net result of -€7,046. Equity is shrinking by ~109.6% per year across the filed fiscal years. Its solvency ranks better than 9% of 9,089 sector peers (NACE 46, fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of perfume and cosmetics
NACE 46450
1 site
Size
€200,537total assets 2024
Staff
0.6 FTE
Equity
-€11,682
Loss
-€7,046
Turnover not published (abridged schema)
Financial health
47 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
4.3%
Structure
Parent
Pharma Collin · 100%
Accounts 69 days overdue0 of 2 deeds read
Why 47- Figures for FY 2024 (filed 12-08-2025)- Founded in 2021- Negative equity -€11,682- 1 financial year not filed after the legal deadline; latest accounts 12 days lateShow the evidence

Checked score

Score 2024
47 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 22% of its sector peers (NACE 46, micro)
Financial strength · tick = 2023
Weak
Solvency 19-4
equity -5.8% of total assets
Liquidity 25-3
short-term debt 105.8% · cash 20.3%
Profitability 64+2
return on assets -3.5%
Bankruptcy probability, 12 months
4.3% Elevated
0%0.5%1.5%4%10%≥ 25%

About 4 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,860 companies)
Last 24 months 11-2024: 1.6% 12-2024: 1.6%● unchanged vs 11-2024 01-2025: 1.6%● unchanged vs 12-2024lowest value 02-2025: 1.6%● unchanged vs 01-2025lowest value 03-2025: 1.6%● unchanged vs 02-2025lowest value 04-2025: 1.9%▲ +0.3 percentage points vs 03-2025 05-2025: 2.4%▲ +0.5 percentage points vs 04-2025 06-2025: 2.5%▲ +0.1 percentage points vs 05-2025 07-2025: 2.6%▲ +0.1 percentage points vs 06-2025 08-2025: 3.3%▲ +0.7 percentage points vs 07-2025 09-2025: 2.1%▼ -1.2 percentage points vs 08-2025 10-2025: 2.1%● unchanged vs 09-2025 11-2025: 2.1%● unchanged vs 10-2025 12-2025: 2.1%● unchanged vs 11-2025 01-2026: 2.1%● unchanged vs 12-2025 02-2026: 2.1%● unchanged vs 01-2026 03-2026: 2.1%● unchanged vs 02-2026 04-2026: 2.1%● unchanged vs 03-2026 05-2026: 2.7%▲ +0.6 percentage points vs 04-2026 06-2026: 2.8%▲ +0.1 percentage points vs 05-2026 07-2026: 2.9%▲ +0.1 percentage points vs 06-2026 08-2026: 2.5%▼ -0.4 percentage points vs 07-2026 09-2026: 2.9%▲ +0.4 percentage points vs 08-2026 10-2026: 4.3%▲ +1.4 percentage points vs 09-2026highest value
No credit on open account
Liquidity short (current ratio 0.77 against 0.66 in 2023; short-term debt: 105.8% and cash: 20.3% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 15% on solvency, 23% on liquidity, 47% on profitability and 3% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
+raises risk○neutral
raises risk · Figures for FY 2024 (filed 12-08-2025)
NBB · annual accounts
raises risk · Founded in 2021
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Negative equity -€11,682
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 12 days late
NBB · filings
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024
Equity per financial year
21222324
2021 to 2024 · latest year -€11,682
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 12-08-2025, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
12 days late
2023
47 days early
2022
22 days late
2021
51 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 16 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · abbreviated…
  2. Annual accounts filedfiscal year 2023 · micro…
  3. Weakest financial yearnet -€11,229

Key points

  • Risk: Negative equityfiscal year 2024: debts exceed assets -€11,682 View
  • Caution: Among the weakest 9% on solvencysector median 44.1% · 9,089 companies -5.8% View
  • Caution: Accounts not fileddeadline was 31-07-2026 69 days late View
  • Controlled by Pharma Collin 100% View
  • Caution: 2 loss-making years in a rowloss fiscal year 2024 -€7,046 View

By topic

Financials

Fiscal year
2024
Total assets
€200,537
Loss
-€7,046
Solvency
-5.8%
Total assets▼ 8.7%
Net result
20212024
Go to Financials

Timeline

Events
5
Since
2022
  1. 22-08-2023Annual accounts filed
  2. 10-06-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of perfume and cosmeticsNACE 46450
Founded
08-01-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.